Turkish Journal of Internal Medicine

Turkish Journal of Internal Medicine

SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control

Yazarlar: Canan ERSOY

Cilt 2 , Sayı 1 , 2020 , Sayfalar 1 - 4

Konular:Genel ve Dahili Tıp

Anahtar Kelimeler:SGLT2 inhibitor,Glycemic control

Özet: Type 2 diabetes mellitus is a growing public health problem worldwide. It has a close relation with metabolic problems like obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular diseases. There are different antidiabetic agents being used in the treatment of diabetes mellitus with different mechanisms of action and a patient centered approach is required when choosing the appropriate treatment option. Sodium-glucose cotransporter (SGLT) 2 inhibitors also called glucoretics or gliflozins are members of a relatively new group of antidiabetic agents with promising cardioprotective and renoprotective effects beyond their glucose lowering efficacies.

ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır
KAYNAK GÖSTER
BibTex
KOPYALA
@article{2020, title={SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control}, volume={2}, number={1}, publisher={Turkish Journal of Internal Medicine}, author={Canan ERSOY}, year={2020}, pages={1–4} }
APA
KOPYALA
Canan ERSOY. (2020). SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control (Vol. 2, pp. 1–4). Vol. 2, pp. 1–4. Turkish Journal of Internal Medicine.
MLA
KOPYALA
Canan ERSOY. SGLT 2 Inhibitors: Antidiabetic Agents with Promising Effects beyond Glucose Control. no. 1, Turkish Journal of Internal Medicine, 2020, pp. 1–4.
Atıf Görüntüle
PDF Görüntüle
Kaynak Görüntüle
Paylaş
Dergi Bilgileri